VistaGen signs licensing deal for stem cell culture technology
VistaGen will utilize the licensed technology to develop hematopoietic precursor stem cells from human pluripotent stem cells, to develop drug screening and cell therapy applications for human blood
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.